Sell RIM!: Against ...
Health Care: Drugs
Cambrex Corporation (CBM: NYSE)
$7.25 0.17 | 2.40%
06/04/12 - 04:01 PM ET
Company Balance Sheet
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 31.92M | 29.61M | 52.36M | 32.54M |
| Receivables | 36.51M | 39.02M | 32.02M | 36.68M |
| Inventories | 62.10M | 61.41M | 58.37M | 61.13M |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 136.61M | 135.13M | 149.41M | 139.16M |
| Property, Plant & Equipment, Gross | 444.70M | 442.00M | 432.48M | 403.59M |
| Accumulated Depreciation & Depletion | 305.07M | 291.51M | 271.33M | 242.09M |
| Property, Plant & Equipment, Net | 139.63M | 150.48M | 161.15M | 161.50M |
| Intangibles | 4.26M | 4.69M | 0.00 | 0.00 |
| Other Non-Current Assets | 18.52M | 23.76M | 4.59M | 5.04M |
| Total Non-Current Assets | 199.14M | 216.62M | 202.10M | 201.92M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 335.74M | 351.75M | 351.52M | 341.07M |
| Accounts Payable | 21.20M | 19.48M | 17.04M | 19.70M |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 18.05M | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | 59.13M | 52.98M | 55.05M | 64.78M |
| Long Term Debt | 98.00M | 115.90M | 120.80M | 123.80M |
| Deferred Income Taxes | 16.24M | 17.89M | 17.30M | 16.14M |
| Other Non-Current Liabilities | 62.03M | 57.34M | 55.09M | 61.57M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 176.27M | 191.13M | 193.19M | 201.51M |
| Total Liabilities | 235.40M | 244.12M | 248.24M | 266.29M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 100.34M | 107.64M | 103.27M | 74.79M |
| Common Par | 3.14M | 3.14M | 3.14M | 3.14M |
| Additional Paid In Capital | 101.65M | 101.27M | 100.50M | 99.88M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | 42.96M | 31.99M | 22.34M | 11.96M |
| Treasury Stock | -15.82M | -16.88M | -18.11M | -19.01M |
| Other Equity Adjustments | -31.59M | -11.89M | -4.60M | -21.18M |
| Total Capitalization | 198.34M | 223.54M | 224.07M | 198.59M |
| Total Equity | 100.34M | 107.64M | 103.27M | 74.79M |
| Total Liabilities & Stock Equity | 335.74M | 351.75M | 351.52M | 341.07M |
| Total Common Shares Outstanding | 29.57M | 29.43M | 29.29M | 29.21M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 1.87M | 1.98M | 2.12M | 2.22M |
| Basic Weighted Shares Outstanding | 29.47M | 29.36M | 29.24M | 29.12M |
| Diluted Weighted Shares Outstanding | 29.56M | 29.47M | 29.27M | 29.16M |
| Number of Employees | 833 | 829 | 854 | 856 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with CBM
- Portfolio NameUser Type
- ContributorStocks At New 52-Week Highs...
- UserSUPRATRADE HOT STOCKS (BUY ...
- UserPART 2 JPMorgan 28th Annual...
- UserPART 3 JPMorgan 27th Annual...
- UserRocket Stocks For The Week ...
- UserValue Seeker
- UserPART 3 JPMorgan 26th Annual...
- Userjmj2321 Portfolio 1
- Userxfirst portfoliox
- UserStian Trellevik Biotech bet
Latest CBM Headlines from TheStreet
- Cambrex Stock Gaps Up On Today's Open (CBM) 05.04.12 | 09:05 am
- Cambrex Corporation Stock Upgraded (CBM) 02.08.12 | 06:02 am
- NYSE Stocks Posting Largest Percentage Decreases 02.07.12 | 06:02 pm
- NYSE Stocks Posting Largest Percentage Decreases 02.07.12 | 01:02 pm
- Cambrex Stock Gaps Down On Today's Open (CBM) 02.07.12 | 09:02 am
- Cambrex Stock Hits New 52-Week High (CBM) 01.27.12 | 01:01 pm
- NYSE Stocks Posting Largest Percentage Increases 11.07.11 | 06:11 pm
- NYSE Stocks Posting Largest Percentage Increases 11.07.11 | 01:11 pm
- Cambrex Stock Soars (CBM) 08.03.11 | 10:08 am
- Cambrex Stock Soars (CBM) 05.12.11 | 04:05 pm
Press Releases for CBM
- Cambrex To Present At UBS 22nd Annual Global Healthcare Services Conference - PR Newswire 02.06.12 | 03:02 pm
- Cambrex And Tillotts Enter A Development And Commercialization Agreement For Proprietary 5-ASA-Based Technology - PR Newswire 07.06.11 | 08:07 am
- Cambrex Zenara Manufacturing Facility Receives European GMP Approval - PR Newswire 01.18.11 | 09:01 am
- Shawn P. Cavanagh Appointed Chief Operating Officer Of Cambrex - PR Newswire 01.07.11 | 01:01 pm
- Cambrex Zenara Supplies Product For Launch Of Nicorette® In India - PR Newswire 01.06.11 | 03:01 pm
- Cambrex Acquires Stake In Zenara Pharma - PR Newswire 11.02.10 | 04:11 pm
- Cambrex Acquires IEP GmbH - PR Newswire 03.22.10 | 01:03 pm
- Cambrex Reports Fourth Quarter And Full Year 2009 Results - PR Newswire 02.10.10 | 05:02 pm
- Cambrex Presentation At The JPMorgan Healthcare Conference To Be Webcast - PR Newswire 01.05.10 | 08:01 am
Partner Headlines for CBM
- If Europe Gets Worse, Stay Away From These 13 U.S. Stocks - Seeking Alpha 11.11.11 | 04:11 pm
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 11.08.11 | 09:11 am
- 9 Small Caps With Positive Earnings Trends - Seeking Alpha 09.16.11 | 08:09 am
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 08.31.11 | 09:08 am
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 08.23.11 | 09:08 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 08.19.11 | 09:08 am
- Shawn P. Cavanagh Appointed Cambrex COO - Benzinga 01.07.11 | 01:01 pm
- Cambrex Acquires Stake in Zenara Pharma for $20M - Benzinga 11.02.10 | 04:11 pm
